Genenta Science SPA Share Price Today: Live Updates & Key Insights

Genenta Science SPA share price today is $0.6228, up 0.86%. The stock opened at $0.6253 against the previous close of $0.6252, with an intraday high of $0.635 and low of $0.592.

Genenta Science SPA Share Price Chart

Genenta Science SPA

us-stock
To Invest in {{usstockname}}
us-stock

Genenta Science SPA Share Price Performance

$0.6228 0.0086(0.86%) GNTA at 23 Mar 2026 01:21 PM Biotechnology
Lowest Today 0.592
Highest Today 0.635
Today’s Open 0.6253
Prev. Close 0.6252
52 Week High 6.20
52 Week Low 0.59
Day’s Range: Low 0.592 High 0.635
52-Week Range: Low 0.59 High 6.20
1 day return -
1 Week return -23.09
1 month return -40.08
3 month return -58.66
6 month return -79.8
1 year return -83.93
3 year return -89.64
5 year return -94.3
10 year return -

Genenta Science SPA Institutional Holdings

Citadel Advisors Llc 2.80

Eurizon Azioni Internazionali 1.54

Weiss Asset Management LP 1.37

Allianz SE 1.00

NORGES BANK 0.97

Alyeska Investment Group, L.P. 0.94

AlTi Global Inc 0.85

Mediolanum Flessibile Futuro Italia LA 0.85

Investitori Flessibile 0.49

Algebris Investment Management (UK) LLP 0.43

Kairos Intl SICAV Italia P 0.39

Investitori America 0.36

Anthilia Small Cap Italia A 0.30

LUX IM Global Medtech HX 0.26

Kairos Intl SICAV Made in Italy Y 0.22

Investitori Longevity A 0.15

Kairos Intl SICAV Patriot P 0.08

Planetarium Anthilia Red B EUR 0.08

SmartHarvest Portfolios, LLC 0.08

Lemanik SICAV High Growth Cap Retail EUR 0.06

Kairos Intl SICAV Opports L/S P 0.06

Lemanik SICAV Eurp Spec Sits Cap Ret EUR 0.05

NATIONAL BANK OF CANADA /FI/ 0.01

GAMMA Investing LLC 0.01

Morgan Stanley - Brokerage Accounts 0.01

EverSource Wealth Advisors, LLC 0.00

Genenta Science SPA Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Genenta Science SPA Fundamentals

Market Cap 14.78 M

PB Ratio 1.0641

PE Ratio 0.0

Enterprise Value 3.18 M

Total Assets 14.82 M

Volume 101921

Genenta Science SPA Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:-41582 -0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-11406747 -11.4M, FY22:-3624844 -3.6M, FY21:-5560705 -5.6M, FY20:-5605734 -5.6M, FY19:-4607275 -4.6M

Quarterly Revenue Q3/2025:null 0.0M, Q2/2024:null 0.0M, Q4/2023:null 0.0M, Q3/2023:null 0.0M, Q2/2023:null 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2024:null 0.0M, Q4/2023:-20883 -0.0M, Q3/2023:null 0.0M, Q2/2023:null 0.0M

Quarterly Net worth Q3/2025:-3826585 -3.8M, Q2/2024:-4038506 -4.0M, Q4/2023:-4788396 -4.8M, Q3/2023:-2443 -0.0M, Q2/2023:null 0.0M

About Genenta Science SPA & investment objective

Company Information Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. Its lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. The company is developing Temferon for use in the treatment of other solid tumor indications, locally advanced hepatocellular carcinoma, and intra-hepatic cholangiocarcinoma. In addition, it develops biologic platform to deliver immunomodulatory molecules directly to the tumor by infiltrating monocytes/macrophages. The company was incorporated in 2014 and is headquartered in Milan, Italy.

Organisation Biotechnology

Employees 13

Industry Biotechnology

CEO Mr. Pierluigi Paracchi

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Genenta Science SPA FAQs

What is the share price of Genenta Science SPA today?

The current share price of Genenta Science SPA is $0.6228.

Can I buy Genenta Science SPA shares in India?

Yes, Indian investors can buy Genenta Science SPA shares by opening an international trading and demat account with Motilal Oswal.

How to buy Genenta Science SPA shares in India?

You can easily invest in Genenta Science SPA shares from India by:

Can I buy fractional shares of Genenta Science SPA?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Genenta Science SPA?

Genenta Science SPA has a market cap of $14.78 M.

In which sector does Genenta Science SPA belong?

Genenta Science SPA operates in the Biotechnology sector.

What documents are required to invest in Genenta Science SPA stocks?

To invest, you typically need:

What is the PE and PB ratio of Genenta Science SPA?

The PE ratio of Genenta Science SPA is N/A and the PB ratio is 1.06.